Fiduciary Alliance LLC Increases Holdings in Oscar Health, Inc. $OSCR

Key Points

• Fiduciary Alliance LLC has significantly increased its holdings in Oscar Health, Inc. by 3,558.0%, acquiring a total of 453,588 shares valued at approximately $9.7 million as of the latest SEC filing.
• Multiple analysts have downgraded Oscar Health's stock ratings, with Wall Street Zen and UBS Group both issuing sell ratings and lowering price targets to around $11.00.
• Oscar Health reported a 29.0% increase in revenue year-over-year, reaching $2.86 billion, despite a slight miss on earnings expectations.

Fiduciary Alliance LLC lifted its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 3,558.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 453,588 shares of the company's stock after buying an additional 441,188 shares during the period. Fiduciary Alliance LLC owned approximately 0.18% of Oscar Health worth $9,725,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in OSCR. Vanguard Group Inc. raised its position in Oscar Health by 3.7% during the first quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock valued at $258,247,000 after purchasing an additional 700,469 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its position in Oscar Health by 4.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock valued at $155,043,000 after purchasing an additional 467,301 shares in the last quarter. Thrive Capital Management LLC raised its position in Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after purchasing an additional 1,588,395 shares in the last quarter. BIT Capital GmbH raised its position in Oscar Health by 1.1% during the first quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after purchasing an additional 47,592 shares in the last quarter. Finally, Glynn Capital Management LLC raised its position in Oscar Health by 14.0% during the first quarter. Glynn Capital Management LLC now owns 3,115,217 shares of the company's stock valued at $40,840,000 after purchasing an additional 381,980 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on OSCR shares. Wall Street Zen downgraded shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Wells Fargo & Company downgraded shares of Oscar Health from an "equal weight" rating to an "underweight" rating and lowered their price target for the stock from $16.00 to $10.00 in a report on Friday, July 11th. Raymond James Financial downgraded shares of Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Piper Sandler lowered their price target on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a report on Thursday, August 14th. Finally, UBS Group reiterated a "sell" rating and set a $11.00 price target (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Four research analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Strong Sell" and an average price target of $12.07.

Oscar Health Trading Down 0.7%

NYSE OSCR traded down $0.14 during trading on Friday, hitting $18.97. 17,336,897 shares of the company's stock traded hands, compared to its average volume of 16,224,456. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The stock has a fifty day moving average of $16.19 and a two-hundred day moving average of $15.27. The firm has a market cap of $4.90 billion, a P/E ratio of -23.42 and a beta of 1.87. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The company's revenue was up 29.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.20 EPS. As a group, sell-side analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.